Invitae Corporation Cash Conversion Cycle 2011-2026 | NVTA

Annual Cash Conversion Cycle Invitae Corporation

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
299	201	55.2	22.9	29.4	-6.89	-43.9	-77.3	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
299	-77.3	59.9

Quarterly Cash Conversion Cycle Invitae Corporation

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
60	67.4	82.8	-	74.9	64.4	60.7	48.7	42.4	34.8	40.2	52.5	76.7	109	60.6	35.6	42	43.4	59.3	55	66.4	66.5	53.7	5.83	-6.76	-8.52	-7.4	11.4	-25.5	-28.4	-38.9	-	-80.8	-82.6	-90.7	-	-155	-271	-214	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
109	-271	8.47

Cash Conversion Cycle of other stocks in the Diagnostics research industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	50.2	-	-6.23 %	$ 30.6 M	Germany
Akumin AKU	36.1	-	-17.87 %	$ 25.9 M	Canada
Aspira Women's Health AWH	-38.7	-	-6.19 %	$ 10.5 M	USA
Bioventus BVS	224	$ 8.87	2.9 %	$ 591 M	USA
Charles River Laboratories International CRL	65	$ 151.97	-2.34 %	$ 7.53 B	USA
Castle Biosciences CSTL	45.9	$ 25.83	1.06 %	$ 717 M	USA
CareDx, Inc CDNA	51.5	$ 17.32	1.82 %	$ 923 M	USA
DexCom DXCM	134	$ 66.34	3.27 %	$ 25.9 B	USA
Accelerate Diagnostics AXDX	364	-	-61.36 %	$ 2.46 M	USA
Exact Sciences Corporation EXAS	42.5	$ 103.85	0.27 %	$ 19.6 B	USA
Global Cord Blood Corporation CO	184	-	-	$ 399 M	China
Genetic Technologies Limited GENE	11 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	142	-	0.12 %	$ 80.1 M	China
Fulgent Genetics FLGT	42.4	$ 14.95	1.22 %	$ 452 M	USA
PRA Health Sciences, Inc. PRAH	1.21 K	-	-	$ 10.7 B	USA
Biodesix BDSX	41.7	$ 17.29	-3.3 %	$ 2.24 B	USA
Guardant Health GH	79.6	$ 87.18	1.98 %	$ 10.9 B	USA
Anixa Biosciences ANIX	275	$ 2.84	0.35 %	$ 92.2 K	USA
Danaher Corporation DHR	77.5	$ 191.39	2.17 %	$ 136 B	USA
Biocept BIOC	78.1	-	-13.05 %	$ 7.29 M	USA
Heska Corporation HSKA	138	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	104	-	-20.0 %	$ 1.06 M	USA
ICON Public Limited Company ICLR	62	$ 97.61	-0.73 %	$ 8.05 B	Irlanda
IQVIA Holdings IQV	73.9	$ 164.89	0.1 %	$ 28.3 B	USA
Illumina ILMN	142	$ 119.28	0.29 %	$ 19 B	USA
Quest Diagnostics Incorporated DGX	39.5	$ 198.94	-0.38 %	$ 22.1 B	USA
QIAGEN N.V. QGEN	122	-	-	$ 10.6 B	Niderland
Agilent Technologies A	111	$ 111.83	0.28 %	$ 34 B	USA
BioNano Genomics BNGO	225	$ 1.11	-	$ 1.41 M	USA
DarioHealth Corp. DRIO	207	$ 8.42	-6.44 %	$ 239 M	Israel
Lantheus Holdings LNTH	97.3	$ 78.5	-1.25 %	$ 5.3 B	USA
Chembio Diagnostics CEMI	111	-	0.22 %	$ 16.8 M	USA
Co-Diagnostics CODX	299	$ 4.4	101.83 %	$ 129 M	USA
Medpace Holdings MEDP	50.4	$ 453.64	0.72 %	$ 13.1 B	USA
Motus GI Holdings MOTS	3.45 K	-	-34.28 %	$ 263 K	Israel
Mettler-Toledo International MTD	66.4	$ 1 198.71	2.13 %	$ 24.7 B	Schweiz
DermTech DMTK	66.7	-	-11.32 %	$ 2.94 M	USA
Neogen Corporation NEOG	150	$ 9.11	0.22 %	$ 1.98 B	USA
National Research Corporation NRC	29.4	$ 17.4	5.33 %	$ 389 M	USA
NeoGenomics NEO	82.4	$ 8.24	4.57 %	$ 1.06 B	USA
Enzo Biochem ENZ	154	-	-8.98 %	$ 14.8 K	USA
Natera NTRA	81.5	$ 197.68	5.23 %	$ 19.5 B	USA
OPKO Health OPK	242	$ 1.19	-	$ 826 M	USA
Pacific Biosciences of California PACB	185	$ 1.36	2.26 %	$ 408 M	USA